Articles On Holista CollTech (ASX:HCT)

Promising green shoots are appearing amid tumbling stocks as China reaches out to Australian producers amid the coronavirus outbreak.  While it’s doom and gloom in Australia’s retail sector, it’s a different story in some of the smaller sto...

Natural wellness company Holista CollTech (ASX: HCT) has gained market traction for its 80Less product by signing a 5-year supply agreement with Rex Industry Berhad. The deal will see Holista’s proprietary sugar formulation be used in a ran...

Short & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorted. Stocks that are shorted have investors betting that they fall. Shorting works by selling stocks you do not actually own in the hope of bu...

The spread of coronavirus has infected global share markets with the contagion of fear. The S&P/ASX 200 Index (INDEXASX: XJO) has fallen more than 10% in the last fortnight as investors flee to safe havens. This week, the Reserve Bank...

In February, mounting coronavirus-led uncertainty finally culminated in a late-month share price bloodbath. After a 3 per cent gain in January, the S&P/ASX Emerging Companies Index – which gauges the health of the microcap sector – had...

The coronavirus has been troubling markets for much of the year and has sent them tumbling this week as its spread abroad becomes more serious. The biggest coronavirus-panic-fuelled share price gains have come from antimicrobial solution ma...

Short & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorted. Stocks that are shorted have investors betting that they fall. Shorting works by selling stocks you do not actually own in the hope of bu...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

As the coronavirus death toll rises to more than 1,000 and the World Health Organisation labels it a global health emergency, share markets are feeling the impact of the outbreak with Australian ASX-listed stocks not immune to the damage. C...

Today’s session proved much kinder to the Aussie market, delivering strong gains across the board as China’s factories came back online. While the dollar remained fairly stagnant, sectors, futures and indices did a 180, rallying to rever...

Following the extension of its Controlled Placement Agreement (CPA) with Acuity Capital, Holista Colltech (HCT) has raised $800,000 The biotech company used the CPA to issue 6.5 million of its shares at an issue price of 12.3 cents Both...

Australian shares rose to a two-week high as investors weighed positive overnight leads against the impact of bushfires and the coronavirus on company earnings. The ASX 200 advanced 51 points or 0.7 per cent to 7063, the index’s highest...

A fresh decade-low for the dollar ended today’s session on a weak note, leaving Australian markets in the red. Despite attempts to climb against the greenback later in the day, the dollar was worth as little as 66.6 US cents this morning...

As the coronavirus death toll overtakes the 2002 SARS outbreak, demand for Holista Colltech’s (HCT) NatShield sanitising spray has risen once again Holista will now ship a further 90,000 units to Kuala Lumpur after the original top-up of 6...

Perth-based biotech company Holista CollTech (ASX: HCT) has received orders for an additional 90,000 NatShield sanitisers to parts of Australia and Asia, just days after the first delivery was sold out amid rising concerns of the spread of...

Since mid-October Zoono (ASX:ZNO) has climbed from 8.2c to $1.20 this morning — a 1,382 per cent spike. And it is still climbing after more good news this morning. The antimicrobial solution maker unveiled its latest distribution agreement...

Gastrointestinal diseases are among the most inconvenient types of illnesses to have, and not just because they may have you running to the loo every five minutes. The field covers many diseases like Irritable Bowel Syndrome (IBS), Crohn’s...

A rebound on Wall Street and the possibility of a surprise rate cut this afternoon helped the share market inch higher despite pressure on resource stocks. The ASX 200 gained momentum after a turgid opening hour, rising 34 points or 0.5...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The Australian share market tumbled 80 points as oil touched its lowest level in a year and Chinese markets re-opened with massive losses. The ASX 200 surrendered its grip on 7,000, falling 1.1 per cent to 6933 by mid-session. At its nad...

Germaphobes have long known about the hand sanitiser companies on the ASX, but the rest of Australia is now learning about them too. New Zealand company Zoono (ASX:ZNO) has seen sales surge, but its stock began moving even before the first...

Panic buying has taken hold in the wake of the spread of the deadly Coronavirus, which has so far claimed 170 lives according to media reports. Overnight British Airways suspended all flights to and from China for the next month. The Austra...

Rising coronavirus fears have ignited demand for Hollister Colltech’s (HTC) NatShield Sanitiser in Kuala Lumpur The company has already sold out of its sanitising spray in Malaysia’s capital To combat rising demand for Natshield, Holista p...

Australian shares recouped almost half of this week’s losses as a slow-starting rally gained momentum. The ASX 200 bounced 44 points or 0.6 per cent to 7038, a day after the index’s biggest plunge of the year. The index slumped 96 point...

Cann Group (ASX:CAN) is pulling back from its original ambitious Mildura cannabis growing warehouse, saying a global oversupply has led it to change plans. Furthermore, major shareholder Aurora says it won’t participate in any new funding r...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

It’s a bleak morning for ASX stocks in the tourism and China-focused sectors. A contravirus began in the Chinese city of Wuhan and while the city is now in lockdown mode, about 5 million people left beforehand due to the Lunar New Year holi...

As Australia prepares for the upcoming Australia Day celebrations on January 26, China is shutting down ahead of the week-long Chinese New Year, or Lunar New Year, national holiday, which starts on January 25. This is the Year of the Rat, w...

Asia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom. The region is a major part of a surge in health spending that is expected over the next few years, as rising lifestyle illnesses and ages...

Insecticide maker Bio-Gene (ASX:BGT) says a trial is proving one of its products is lethal against a particularly difficult to kill mosquito. The Anopheles gambiae mosquito carries malaria and is increasingly resistant to more commonly used...

Holista CollTech Limited (ASX: HCT) announced that it had obtained the necessary regulatory clearance for the sale of its proprietary low-calorie sugar, 80Less in the United States and Canada. The company intends 80Less to address the growi...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

As the market players are aware, global stock markets are generally affected by uncertainties related to the broader macro-economic environment as well as the overall health of the global economy. However, in the current scenario, it can be...

Products such as food, household goods, beverage, alcohol, tobacco, wellness products etc. are considered to be non-cyclical due to their consistent need from the end-users, irrespective of the general economic scenario. Companies that cate...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...